patient_id,baseline_week,followup_week,V_WT_change_pct,V_TC_change_pct,V_ET_change_pct,ET_fraction_change,TC_fraction_change,prediction,true_label,rano_rating,confidence,correct,explanation
Patient-001,week-000-2,week-044,-5.6,-5.6,0.0,0.0,0.0,Non-Progression,Non-Progression,SD,0.534,True,Predicted NON-PROGRESSION based on stable total volume (change: -6%). Confidence: 53.4%.
Patient-001,week-000-2,week-056,-69.7,-93.6,0.0,0.0,-78.9,Non-Progression,Progression,PD,0.788,False,Predicted NON-PROGRESSION based on significant tumor reduction (-70%). Confidence: 78.8%.
Patient-002,week-000,week-021,-71.2,-19.6,0.0,0.0,64.2,Non-Progression,Non-Progression,SD,0.728,True,Predicted NON-PROGRESSION based on significant tumor reduction (-71%). Confidence: 72.8%.
Patient-002,week-000,week-037,-9.2,101.8,0.0,0.0,43.7,Progression,Progression,PD,0.618,True,Predicted PROGRESSION due to tumor core (TC) increased by 102%. Confidence: 61.8%.
Patient-002,week-000,week-047,67.6,54.7,0.0,0.0,-2.7,Progression,Progression,PD,0.628,True,Predicted PROGRESSION due to tumor core (TC) increased by 55%. Confidence: 62.8%.
Patient-003,week-000-2,week-014,-65.8,-65.1,0.0,0.0,2.0,Non-Progression,Non-Progression,SD,0.584,True,Predicted NON-PROGRESSION based on significant tumor reduction (-66%). Confidence: 58.4%.
Patient-003,week-000-2,week-027,-48.8,-47.8,0.0,0.0,2.0,Non-Progression,Progression,PD,0.537,False,Predicted NON-PROGRESSION based on significant tumor reduction (-49%). Confidence: 53.7%.
Patient-003,week-000-2,week-038,393.0,215.3,0.0,0.0,-35.3,Progression,Progression,PD,0.756,True,Predicted PROGRESSION due to tumor core (TC) increased by 215%. Confidence: 75.6%.
Patient-004,week-000-2,week-020,19.3,19.3,0.0,0.0,0.0,Non-Progression,Progression,PD,0.543,False,Predicted NON-PROGRESSION based on stable total volume (change: +19%). Confidence: 54.3%.
Patient-004,week-000-2,week-038,-35.0,-67.4,0.0,0.0,-49.8,Progression,Progression,PD,0.718,True,Predicted PROGRESSION due to region composition changes suggest progression despite 35% total volume decrease. Confidence: 71.8%.
Patient-004,week-000-2,week-057,30.6,9.2,0.0,0.0,-16.4,Progression,Progression,PD,0.719,True,Predicted PROGRESSION due to whole tumor increased by 31%. Confidence: 71.9%.
Patient-004,week-000-2,week-071,-15.0,-16.2,0.0,0.0,-1.4,Progression,Non-Progression,PR,0.697,False,Predicted PROGRESSION due to region composition changes suggest progression despite 15% total volume decrease. Confidence: 69.7%.
Patient-004,week-000-2,week-086,8.0,-2.9,0.0,0.0,-10.0,Progression,Progression,PD,0.721,True,Predicted PROGRESSION due to combined regional patterns indicate progression. Confidence: 72.1%.
Patient-005,week-000-2,week-015,-34.9,-36.8,0.0,0.0,-2.9,Progression,Non-Progression,SD,0.686,False,Predicted PROGRESSION due to region composition changes suggest progression despite 35% total volume decrease. Confidence: 68.6%.
Patient-006,week-000,week-015,-81.1,-78.7,0.0,0.0,10.4,Progression,Non-Progression,SD,0.616,False,Predicted PROGRESSION due to region composition changes suggest progression despite 81% total volume decrease. Confidence: 61.6%.
Patient-006,week-000,week-027,-78.0,-72.8,0.0,0.0,18.9,Non-Progression,Non-Progression,SD,0.712,True,Predicted NON-PROGRESSION based on significant tumor reduction (-78%). Confidence: 71.2%.
Patient-006,week-000,week-039,-70.7,-64.2,0.0,0.0,18.0,Progression,Non-Progression,SD,0.592,False,Predicted PROGRESSION due to region composition changes suggest progression despite 71% total volume decrease. Confidence: 59.2%.
Patient-006,week-000,week-053,-72.5,-66.0,0.0,0.0,18.9,Non-Progression,Non-Progression,SD,0.603,True,Predicted NON-PROGRESSION based on significant tumor reduction (-72%). Confidence: 60.3%.
Patient-006,week-000,week-067,-69.3,-62.2,0.0,0.0,18.9,Non-Progression,Non-Progression,SD,0.631,True,Predicted NON-PROGRESSION based on significant tumor reduction (-69%). Confidence: 63.1%.
Patient-006,week-000,week-083,-67.9,-60.5,0.0,0.0,18.9,Progression,Non-Progression,SD,0.525,False,Predicted PROGRESSION due to region composition changes suggest progression despite 68% total volume decrease. Confidence: 52.5%.
Patient-006,week-000,week-097,-68.6,-61.3,0.0,0.0,18.9,Non-Progression,Progression,PD,0.673,False,Predicted NON-PROGRESSION based on significant tumor reduction (-69%). Confidence: 67.3%.
Patient-006,week-000,week-112,-68.5,-62.7,0.0,0.0,15.0,Progression,Progression,PD,0.631,True,Predicted PROGRESSION due to region composition changes suggest progression despite 69% total volume decrease. Confidence: 63.1%.
Patient-006,week-000,week-121,-81.9,-77.7,0.0,0.0,18.9,Non-Progression,Non-Progression,SD,0.651,True,Predicted NON-PROGRESSION based on significant tumor reduction (-82%). Confidence: 65.1%.
Patient-006,week-000,week-131,-92.1,-90.5,0.0,0.0,15.8,Progression,Progression,PD,0.51,True,Predicted PROGRESSION due to region composition changes suggest progression despite 92% total volume decrease. Confidence: 51.0%.
Patient-006,week-000,week-135,-84.9,-83.0,0.0,0.0,10.2,Progression,Progression,PD,0.51,True,Predicted PROGRESSION due to region composition changes suggest progression despite 85% total volume decrease. Confidence: 51.0%.
Patient-007,week-000,week-015,-97.4,-97.1,0.0,0.0,8.7,Non-Progression,Progression,PD,0.834,False,Predicted NON-PROGRESSION based on significant tumor reduction (-97%). Confidence: 83.4%.
Patient-007,week-000,week-028,-94.2,-93.7,0.0,0.0,8.7,Non-Progression,Progression,PD,0.658,False,Predicted NON-PROGRESSION based on significant tumor reduction (-94%). Confidence: 65.8%.
Patient-007,week-000,week-041,-92.6,-91.9,0.0,0.0,8.7,Non-Progression,Progression,PD,0.668,False,Predicted NON-PROGRESSION based on significant tumor reduction (-93%). Confidence: 66.8%.
Patient-007,week-000,week-055,-90.2,-89.9,0.0,0.0,2.5,Progression,Progression,PD,0.574,True,Predicted PROGRESSION due to region composition changes suggest progression despite 90% total volume decrease. Confidence: 57.4%.
Patient-007,week-000,week-064,-78.2,-79.2,0.0,0.0,-4.2,Progression,Progression,PD,0.666,True,Predicted PROGRESSION due to region composition changes suggest progression despite 78% total volume decrease. Confidence: 66.6%.
Patient-007,week-000,week-075,-58.8,-63.0,0.0,0.0,-9.3,Progression,Progression,PD,0.738,True,Predicted PROGRESSION due to region composition changes suggest progression despite 59% total volume decrease. Confidence: 73.8%.
Patient-007,week-000,week-089,-39.4,-39.4,0.0,0.0,-0.1,Progression,Progression,PD,0.739,True,Predicted PROGRESSION due to region composition changes suggest progression despite 39% total volume decrease. Confidence: 73.9%.
Patient-007,week-000,week-105,-55.2,-62.9,0.0,0.0,-15.8,Progression,Progression,PD,0.737,True,Predicted PROGRESSION due to region composition changes suggest progression despite 55% total volume decrease. Confidence: 73.7%.
Patient-008,week-000,week-017,-83.4,-84.1,0.0,0.0,-4.1,Progression,Progression,PD,0.682,True,Predicted PROGRESSION due to region composition changes suggest progression despite 83% total volume decrease. Confidence: 68.2%.
Patient-008,week-000,week-066,-78.2,-75.7,0.0,0.0,10.1,Progression,Progression,PD,0.69,True,Predicted PROGRESSION due to region composition changes suggest progression despite 78% total volume decrease. Confidence: 69.0%.
Patient-008,week-000,week-085,-80.3,-79.6,0.0,0.0,3.0,Progression,Progression,PD,0.674,True,Predicted PROGRESSION due to region composition changes suggest progression despite 80% total volume decrease. Confidence: 67.4%.
Patient-009,week-000-2,week-014,144.9,100.1,0.0,0.0,-18.3,Progression,Non-Progression,SD,0.826,False,Predicted PROGRESSION due to tumor core (TC) increased by 100%. Confidence: 82.6%.
Patient-009,week-000-2,week-024,-87.1,-87.1,0.0,0.0,0.0,Non-Progression,Non-Progression,CR,0.814,True,Predicted NON-PROGRESSION based on significant tumor reduction (-87%). Confidence: 81.4%.
Patient-009,week-000-2,week-066,-32.5,-41.5,0.0,0.0,-13.4,Progression,Progression,PD,0.642,True,Predicted PROGRESSION due to region composition changes suggest progression despite 32% total volume decrease. Confidence: 64.2%.
Patient-010,week-000,week-015,-82.3,-80.1,0.0,0.0,8.7,Progression,Non-Progression,SD,0.618,False,Predicted PROGRESSION due to region composition changes suggest progression despite 82% total volume decrease. Confidence: 61.8%.
Patient-011,week-000,week-021,-75.8,-74.3,0.0,0.0,5.2,Non-Progression,Non-Progression,SD,0.612,True,Predicted NON-PROGRESSION based on significant tumor reduction (-76%). Confidence: 61.2%.
Patient-011,week-000,week-028,60.2,71.9,0.0,0.0,6.0,Progression,Progression,PD,0.618,True,Predicted PROGRESSION due to tumor core (TC) increased by 72%. Confidence: 61.8%.
Patient-012,week-000-2,week-016,16.8,-3.5,0.0,0.0,-17.4,Non-Progression,Non-Progression,SD,0.568,True,Predicted NON-PROGRESSION based on stable total volume (change: +17%). Confidence: 56.8%.
Patient-012,week-000-2,week-048,564.6,564.6,0.0,0.0,0.0,Progression,Progression,PD,0.63,True,Predicted PROGRESSION due to tumor core (TC) increased by 565%. Confidence: 63.0%.
Patient-012,week-000-2,week-073,618.7,618.7,0.0,0.0,0.0,Progression,Progression,PD,0.653,True,Predicted PROGRESSION due to tumor core (TC) increased by 619%. Confidence: 65.3%.
Patient-012,week-000-2,week-084,771.8,754.1,0.0,0.0,-2.0,Progression,Progression,PD,0.768,True,Predicted PROGRESSION due to tumor core (TC) increased by 754%. Confidence: 76.8%.
Patient-013,week-000,week-017,-92.1,-91.1,0.0,0.0,10.6,Non-Progression,Non-Progression,SD,0.529,True,Predicted NON-PROGRESSION based on significant tumor reduction (-92%). Confidence: 52.9%.
Patient-013,week-000,week-030,-79.5,-79.9,0.0,0.0,-1.3,Progression,Progression,PD,0.658,True,Predicted PROGRESSION due to region composition changes suggest progression despite 80% total volume decrease. Confidence: 65.8%.
Patient-014,week-000,week-012,-93.5,-91.2,0.0,0.0,25.5,Non-Progression,Non-Progression,SD,0.778,True,Predicted NON-PROGRESSION based on significant tumor reduction (-93%). Confidence: 77.8%.
Patient-015,week-000-2,week-021,-80.0,-80.0,0.0,0.0,0.1,Non-Progression,Non-Progression,CR,0.815,True,Predicted NON-PROGRESSION based on significant tumor reduction (-80%). Confidence: 81.5%.
Patient-015,week-000-2,week-037,-62.9,-62.8,0.0,0.0,0.1,Non-Progression,Non-Progression,CR,0.569,True,Predicted NON-PROGRESSION based on significant tumor reduction (-63%). Confidence: 56.9%.
Patient-015,week-000-2,week-056,-50.4,-50.3,0.0,0.0,0.1,Non-Progression,Progression,PD,0.51,False,Predicted NON-PROGRESSION based on significant tumor reduction (-50%). Confidence: 51.0%.
Patient-015,week-000-2,week-078,-29.7,-30.4,0.0,0.0,-1.1,Progression,Progression,PD,0.613,True,Predicted PROGRESSION due to region composition changes suggest progression despite 30% total volume decrease. Confidence: 61.3%.
Patient-015,week-000-2,week-083,-36.0,-36.7,0.0,0.0,-1.0,Progression,Progression,PD,0.605,True,Predicted PROGRESSION due to region composition changes suggest progression despite 36% total volume decrease. Confidence: 60.5%.
Patient-015,week-000-2,week-099,-23.2,-23.3,0.0,0.0,-0.1,Progression,Progression,PD,0.509,True,Predicted PROGRESSION due to region composition changes suggest progression despite 23% total volume decrease. Confidence: 50.9%.
Patient-015,week-000-2,week-111,-17.4,-17.3,0.0,0.0,0.1,Non-Progression,Progression,PD,0.534,False,Predicted NON-PROGRESSION based on stable total volume (change: -17%). Confidence: 53.4%.
Patient-015,week-000-2,week-126,-20.1,-20.0,0.0,0.0,0.1,Progression,Progression,PD,0.517,True,Predicted PROGRESSION due to region composition changes suggest progression despite 20% total volume decrease. Confidence: 51.7%.
Patient-015,week-000-2,week-140,42.8,30.8,0.0,0.0,-8.5,Progression,Progression,PD,0.658,True,Predicted PROGRESSION due to tumor core (TC) increased by 31%. Confidence: 65.8%.
Patient-015,week-000-2,week-145,409.5,316.0,0.0,0.0,-18.3,Progression,Progression,PD,0.778,True,Predicted PROGRESSION due to tumor core (TC) increased by 316%. Confidence: 77.8%.
Patient-017,week-000,week-016,-37.1,-35.4,0.0,0.0,1.9,Progression,Non-Progression,SD,0.626,False,Predicted PROGRESSION due to region composition changes suggest progression despite 37% total volume decrease. Confidence: 62.6%.
Patient-017,week-000,week-035,268.3,358.2,0.0,0.0,17.3,Progression,Progression,PD,0.758,True,Predicted PROGRESSION due to tumor core (TC) increased by 358%. Confidence: 75.8%.
Patient-018,week-000,week-017,-58.4,-61.0,0.0,0.0,-5.9,Non-Progression,Non-Progression,SD,0.634,True,Predicted NON-PROGRESSION based on significant tumor reduction (-58%). Confidence: 63.4%.
Patient-018,week-000,week-034,67.5,61.6,0.0,0.0,-3.3,Progression,Progression,PD,0.652,True,Predicted PROGRESSION due to tumor core (TC) increased by 62%. Confidence: 65.2%.
Patient-018,week-000,week-063,-93.5,-93.1,0.0,0.0,5.3,Non-Progression,Non-Progression,CR,0.869,True,Predicted NON-PROGRESSION based on significant tumor reduction (-93%). Confidence: 86.9%.
Patient-018,week-000,week-082,-55.8,-53.3,0.0,0.0,5.3,Non-Progression,Non-Progression,CR,0.712,True,Predicted NON-PROGRESSION based on significant tumor reduction (-56%). Confidence: 71.2%.
Patient-021,week-000-2,week-022,173.2,110.9,0.0,0.0,-22.3,Progression,Progression,PD,0.75,True,Predicted PROGRESSION due to tumor core (TC) increased by 111%. Confidence: 75.0%.
Patient-021,week-000-2,week-035,-12.1,-10.1,0.0,0.0,2.3,Non-Progression,Non-Progression,PR,0.532,True,Predicted NON-PROGRESSION based on stable total volume (change: -12%). Confidence: 53.2%.
Patient-022,week-000,week-037,33.2,69.8,0.0,0.0,16.1,Progression,Progression,PD,0.77,True,Predicted PROGRESSION due to tumor core (TC) increased by 70%. Confidence: 77.0%.
Patient-022,week-000,week-045,-89.4,-82.6,0.0,0.0,37.4,Progression,Progression,PD,0.577,True,Predicted PROGRESSION due to region composition changes suggest progression despite 89% total volume decrease. Confidence: 57.7%.
Patient-022,week-000,week-053,-41.7,-29.8,0.0,0.0,11.9,Progression,Progression,PD,0.75,True,Predicted PROGRESSION due to region composition changes suggest progression despite 42% total volume decrease. Confidence: 75.0%.
Patient-023,week-000,week-024,-100.0,-100.0,0.0,0.0,-77.2,Non-Progression,Non-Progression,SD,0.723,True,Predicted NON-PROGRESSION based on significant tumor reduction (-100%). Confidence: 72.3%.
Patient-023,week-000,week-039,-94.1,-92.9,0.0,0.0,16.3,Non-Progression,Non-Progression,SD,0.739,True,Predicted NON-PROGRESSION based on significant tumor reduction (-94%). Confidence: 73.9%.
Patient-023,week-000,week-046,-89.8,-87.2,0.0,0.0,19.6,Non-Progression,Progression,PD,0.769,False,Predicted NON-PROGRESSION based on significant tumor reduction (-90%). Confidence: 76.9%.
Patient-023,week-000,week-059,-87.1,-83.2,0.0,0.0,22.8,Non-Progression,Progression,PD,0.848,False,Predicted NON-PROGRESSION based on significant tumor reduction (-87%). Confidence: 84.8%.
Patient-023,week-000,week-084,-83.7,-78.9,0.0,0.0,22.8,Non-Progression,Non-Progression,CR,0.817,True,Predicted NON-PROGRESSION based on significant tumor reduction (-84%). Confidence: 81.7%.
Patient-023,week-000,week-097,-17.2,-17.0,0.0,0.0,0.2,Progression,Progression,PD,0.624,True,Predicted PROGRESSION due to region composition changes suggest progression despite 17% total volume decrease. Confidence: 62.4%.
Patient-023,week-000,week-111,-21.0,-24.2,0.0,0.0,-3.1,Progression,Progression,PD,0.656,True,Predicted PROGRESSION due to region composition changes suggest progression despite 21% total volume decrease. Confidence: 65.6%.
Patient-023,week-000,week-115,-16.1,-24.7,0.0,0.0,-7.9,Progression,Progression,PD,0.61,True,Predicted PROGRESSION due to region composition changes suggest progression despite 16% total volume decrease. Confidence: 61.0%.
Patient-023,week-000,week-127,793.2,687.0,0.0,0.0,-9.2,Progression,Progression,PD,0.835,True,Predicted PROGRESSION due to tumor core (TC) increased by 687%. Confidence: 83.5%.
Patient-025,week-000,week-019,-100.0,-100.0,0.0,0.0,-63.2,Non-Progression,Non-Progression,SD,0.794,True,Predicted NON-PROGRESSION based on significant tumor reduction (-100%). Confidence: 79.4%.
Patient-025,week-000,week-030,-87.2,-79.8,0.0,0.0,36.8,Non-Progression,Non-Progression,SD,0.779,True,Predicted NON-PROGRESSION based on significant tumor reduction (-87%). Confidence: 77.9%.
Patient-025,week-000,week-043,-56.3,-30.8,0.0,0.0,36.8,Non-Progression,Progression,PD,0.705,False,Predicted NON-PROGRESSION based on significant tumor reduction (-56%). Confidence: 70.5%.
Patient-025,week-000,week-055,46.9,84.0,0.0,0.0,15.9,Progression,Progression,PD,0.622,True,Predicted PROGRESSION due to tumor core (TC) increased by 84%. Confidence: 62.2%.
Patient-025,week-000,week-070,857.9,1225.6,0.0,0.0,24.3,Progression,Progression,PD,0.718,True,Predicted PROGRESSION due to tumor core (TC) increased by 1226%. Confidence: 71.8%.
Patient-027,week-000-2,week-014,200.0,149.3,0.0,0.0,-16.9,Progression,Progression,PD,0.851,True,Predicted PROGRESSION due to tumor core (TC) increased by 149%. Confidence: 85.1%.
Patient-028,week-000-2,week-015,-63.6,-65.0,0.0,0.0,-3.9,Progression,Progression,PD,0.744,True,Predicted PROGRESSION due to region composition changes suggest progression despite 64% total volume decrease. Confidence: 74.4%.
Patient-028,week-000-2,week-030,-14.4,-28.1,0.0,0.0,-16.0,Progression,Progression,PD,0.779,True,Predicted PROGRESSION due to region composition changes suggest progression despite 14% total volume decrease. Confidence: 77.9%.
Patient-028,week-000-2,week-038,-15.7,-39.9,0.0,0.0,-28.7,Progression,Progression,PD,0.751,True,Predicted PROGRESSION due to region composition changes suggest progression despite 16% total volume decrease. Confidence: 75.1%.
Patient-029,week-000-2,week-010,-7.7,-7.6,0.0,0.0,0.2,Non-Progression,Non-Progression,PR,0.54,True,Predicted NON-PROGRESSION based on stable total volume (change: -8%). Confidence: 54.0%.
Patient-029,week-000-2,week-022,29.4,29.6,0.0,0.0,0.2,Non-Progression,Non-Progression,PR,0.587,True,Predicted NON-PROGRESSION based on regional features indicate stability. Confidence: 58.7%.
Patient-029,week-000-2,week-033,43.0,43.3,0.0,0.0,0.2,Non-Progression,Non-Progression,CR,0.653,True,Predicted NON-PROGRESSION based on regional features indicate stability. Confidence: 65.3%.
Patient-029,week-000-2,week-045,82.5,82.8,0.0,0.0,0.2,Non-Progression,Non-Progression,CR,0.625,True,Predicted NON-PROGRESSION based on regional features indicate stability. Confidence: 62.5%.
Patient-029,week-000-2,week-059,59.6,59.9,0.0,0.0,0.2,Non-Progression,Non-Progression,CR,0.657,True,Predicted NON-PROGRESSION based on regional features indicate stability. Confidence: 65.7%.
Patient-029,week-000-2,week-100,84.6,84.9,0.0,0.0,0.2,Progression,Non-Progression,CR,0.512,False,Predicted PROGRESSION due to tumor core (TC) increased by 85%. Confidence: 51.2%.
Patient-029,week-000-2,week-112,74.8,75.0,0.0,0.0,0.2,Non-Progression,Non-Progression,CR,0.6,True,Predicted NON-PROGRESSION based on regional features indicate stability. Confidence: 60.0%.
Patient-029,week-000-2,week-152,55.9,56.2,0.0,0.0,0.2,Non-Progression,Non-Progression,CR,0.595,True,Predicted NON-PROGRESSION based on regional features indicate stability. Confidence: 59.5%.
Patient-029,week-000-2,week-165,62.0,62.3,0.0,0.0,0.2,Non-Progression,Non-Progression,CR,0.559,True,Predicted NON-PROGRESSION based on regional features indicate stability. Confidence: 55.9%.
Patient-029,week-000-2,week-207,35.4,35.6,0.0,0.0,0.2,Non-Progression,Non-Progression,CR,0.598,True,Predicted NON-PROGRESSION based on regional features indicate stability. Confidence: 59.8%.
Patient-029,week-000-2,week-223,12.4,7.9,0.0,0.0,-4.0,Progression,Progression,PD,0.677,True,Predicted PROGRESSION due to combined regional patterns indicate progression. Confidence: 67.7%.
Patient-030,week-000,week-017,-88.9,-72.5,0.0,0.0,59.6,Non-Progression,Non-Progression,SD,0.79,True,Predicted NON-PROGRESSION based on significant tumor reduction (-89%). Confidence: 79.0%.
Patient-030,week-000,week-025,-89.6,-74.1,0.0,0.0,59.6,Non-Progression,Non-Progression,SD,0.859,True,Predicted NON-PROGRESSION based on significant tumor reduction (-90%). Confidence: 85.9%.
Patient-030,week-000,week-041,-89.6,-74.6,0.0,0.0,58.1,Non-Progression,Progression,PD,0.74,False,Predicted NON-PROGRESSION based on significant tumor reduction (-90%). Confidence: 74.0%.
Patient-030,week-000,week-052,4.2,144.9,0.0,0.0,54.5,Progression,Progression,PD,0.585,True,Predicted PROGRESSION due to tumor core (TC) increased by 145%. Confidence: 58.5%.
Patient-030,week-000,week-067,-36.6,57.0,0.0,0.0,59.6,Non-Progression,Non-Progression,PR,0.56,True,Predicted NON-PROGRESSION based on significant tumor reduction (-37%). Confidence: 56.0%.
Patient-030,week-000,week-085,66.6,128.8,0.0,0.0,15.1,Progression,Progression,PD,0.599,True,Predicted PROGRESSION due to tumor core (TC) increased by 129%. Confidence: 59.9%.
Patient-031,week-000,week-015,-75.4,-73.0,0.0,0.0,8.4,Progression,Non-Progression,SD,0.6,False,Predicted PROGRESSION due to region composition changes suggest progression despite 75% total volume decrease. Confidence: 60.0%.
Patient-031,week-000,week-032,-90.8,-88.9,0.0,0.0,17.1,Non-Progression,Non-Progression,CR,0.862,True,Predicted NON-PROGRESSION based on significant tumor reduction (-91%). Confidence: 86.2%.
Patient-031,week-000,week-046,-83.0,-79.6,0.0,0.0,17.1,Non-Progression,Non-Progression,CR,0.683,True,Predicted NON-PROGRESSION based on significant tumor reduction (-83%). Confidence: 68.3%.
Patient-031,week-000,week-059,-80.3,-76.2,0.0,0.0,17.1,Non-Progression,Non-Progression,CR,0.713,True,Predicted NON-PROGRESSION based on significant tumor reduction (-80%). Confidence: 71.3%.
Patient-031,week-000,week-074,-83.1,-79.6,0.0,0.0,17.1,Non-Progression,Non-Progression,CR,0.693,True,Predicted NON-PROGRESSION based on significant tumor reduction (-83%). Confidence: 69.3%.
Patient-031,week-000,week-087,-78.6,-74.2,0.0,0.0,17.1,Non-Progression,Non-Progression,CR,0.74,True,Predicted NON-PROGRESSION based on significant tumor reduction (-79%). Confidence: 74.0%.
Patient-031,week-000,week-105,-79.0,-74.7,0.0,0.0,17.1,Non-Progression,Non-Progression,CR,0.673,True,Predicted NON-PROGRESSION based on significant tumor reduction (-79%). Confidence: 67.3%.
Patient-031,week-000,week-123,-78.9,-74.5,0.0,0.0,17.1,Non-Progression,Non-Progression,CR,0.648,True,Predicted NON-PROGRESSION based on significant tumor reduction (-79%). Confidence: 64.8%.
Patient-031,week-000,week-142,-77.2,-73.3,0.0,0.0,14.2,Non-Progression,Progression,PD,0.502,False,Predicted NON-PROGRESSION based on significant tumor reduction (-77%). Confidence: 50.2%.
Patient-031,week-000,week-151,-4.4,15.2,0.0,0.0,17.0,Progression,Progression,PD,0.521,True,Predicted PROGRESSION due to region composition changes suggest progression despite 4% total volume decrease. Confidence: 52.1%.
Patient-031,week-000,week-165,-78.8,-74.9,0.0,0.0,15.2,Progression,Progression,PD,0.515,True,Predicted PROGRESSION due to region composition changes suggest progression despite 79% total volume decrease. Confidence: 51.5%.
Patient-031,week-000,week-184,34.9,27.9,0.0,0.0,-4.3,Progression,Progression,PD,0.751,True,Predicted PROGRESSION due to tumor core (TC) increased by 28%. Confidence: 75.1%.
Patient-031,week-000,week-190,199.1,183.3,0.0,0.0,-4.4,Progression,Progression,PD,0.783,True,Predicted PROGRESSION due to tumor core (TC) increased by 183%. Confidence: 78.3%.
Patient-032,week-000-2,week-013,-85.2,-85.2,0.0,0.0,0.0,Non-Progression,Non-Progression,CR,0.808,True,Predicted NON-PROGRESSION based on significant tumor reduction (-85%). Confidence: 80.8%.
Patient-032,week-000-2,week-027,-2.5,-2.5,0.0,0.0,0.0,Non-Progression,Non-Progression,CR,0.605,True,Predicted NON-PROGRESSION based on stable total volume (change: -3%). Confidence: 60.5%.
Patient-032,week-000-2,week-040,21.5,14.4,0.0,0.0,-5.9,Progression,Non-Progression,CR,0.589,False,Predicted PROGRESSION due to combined regional patterns indicate progression. Confidence: 58.9%.
Patient-032,week-000-2,week-044,45.3,33.8,0.0,0.0,-7.9,Progression,Progression,PD,0.592,True,Predicted PROGRESSION due to tumor core (TC) increased by 34%. Confidence: 59.2%.
Patient-032,week-000-2,week-055,53.5,32.8,0.0,0.0,-13.5,Progression,Progression,PD,0.575,True,Predicted PROGRESSION due to tumor core (TC) increased by 33%. Confidence: 57.5%.
Patient-032,week-000-2,week-067,100.5,93.9,0.0,0.0,-3.3,Progression,Progression,PD,0.616,True,Predicted PROGRESSION due to tumor core (TC) increased by 94%. Confidence: 61.6%.
Patient-032,week-000-2,week-075,19.4,18.4,0.0,0.0,-0.9,Non-Progression,Progression,PD,0.596,False,Predicted NON-PROGRESSION based on stable total volume (change: +19%). Confidence: 59.6%.
Patient-032,week-000-2,week-085,89.1,89.1,0.0,0.0,0.0,Progression,Non-Progression,CR,0.531,False,Predicted PROGRESSION due to tumor core (TC) increased by 89%. Confidence: 53.1%.
Patient-032,week-000-2,week-096,91.9,91.9,0.0,0.0,0.0,Non-Progression,Progression,PD,0.536,False,Predicted NON-PROGRESSION based on regional features indicate stability. Confidence: 53.6%.
Patient-033,week-000,week-006,-93.0,-98.5,0.0,0.0,-62.2,Non-Progression,Non-Progression,SD,0.76,True,Predicted NON-PROGRESSION based on significant tumor reduction (-93%). Confidence: 76.0%.
Patient-033,week-000,week-031,-74.4,-67.7,0.0,0.0,20.5,Progression,Progression,PD,0.568,True,Predicted PROGRESSION due to region composition changes suggest progression despite 74% total volume decrease. Confidence: 56.8%.
Patient-033,week-000,week-049,-74.1,-68.5,0.0,0.0,17.0,Progression,Progression,PD,0.504,True,Predicted PROGRESSION due to region composition changes suggest progression despite 74% total volume decrease. Confidence: 50.4%.
Patient-033,week-000,week-063,-66.1,-56.9,0.0,0.0,21.2,Non-Progression,Progression,PD,0.633,False,Predicted NON-PROGRESSION based on significant tumor reduction (-66%). Confidence: 63.3%.
Patient-033,week-000,week-076,-60.0,-50.5,0.0,0.0,18.8,Progression,Progression,PD,0.633,True,Predicted PROGRESSION due to region composition changes suggest progression despite 60% total volume decrease. Confidence: 63.3%.
Patient-033,week-000,week-084,-62.9,-59.4,0.0,0.0,7.6,Progression,Progression,PD,0.685,True,Predicted PROGRESSION due to region composition changes suggest progression despite 63% total volume decrease. Confidence: 68.5%.
Patient-034,week-000-2,week-014,-91.0,-92.4,0.0,0.0,-15.1,Non-Progression,Non-Progression,SD,0.69,True,Predicted NON-PROGRESSION based on significant tumor reduction (-91%). Confidence: 69.0%.
Patient-034,week-000-2,week-028,-87.8,-87.9,0.0,0.0,-0.4,Progression,Progression,PD,0.543,True,Predicted PROGRESSION due to region composition changes suggest progression despite 88% total volume decrease. Confidence: 54.3%.
Patient-034,week-000-2,week-040,-68.0,-76.8,0.0,0.0,-27.3,Progression,Progression,PD,0.724,True,Predicted PROGRESSION due to region composition changes suggest progression despite 68% total volume decrease. Confidence: 72.4%.
Patient-034,week-000-2,week-058,-60.8,-61.0,0.0,0.0,-0.4,Progression,Progression,PD,0.74,True,Predicted PROGRESSION due to region composition changes suggest progression despite 61% total volume decrease. Confidence: 74.0%.
Patient-035,week-000-2,week-008,48.7,30.5,0.0,0.0,-12.2,Progression,Non-Progression,SD,0.846,False,Predicted PROGRESSION due to tumor core (TC) increased by 30%. Confidence: 84.6%.
Patient-035,week-000-2,week-019,-43.0,-60.1,0.0,0.0,-30.0,Progression,Non-Progression,SD,0.721,False,Predicted PROGRESSION due to region composition changes suggest progression despite 43% total volume decrease. Confidence: 72.1%.
Patient-035,week-000-2,week-024,-11.5,-30.1,0.0,0.0,-21.1,Progression,Progression,PD,0.765,True,Predicted PROGRESSION due to region composition changes suggest progression despite 11% total volume decrease. Confidence: 76.5%.
Patient-035,week-000-2,week-036,55.9,2.7,0.0,0.0,-34.1,Progression,Progression,PD,0.703,True,Predicted PROGRESSION due to whole tumor increased by 56%. Confidence: 70.3%.
Patient-035,week-000-2,week-050,89.0,33.2,0.0,0.0,-29.5,Progression,Progression,PD,0.793,True,Predicted PROGRESSION due to tumor core (TC) increased by 33%. Confidence: 79.3%.
Patient-036,week-000,week-005,-92.1,-69.2,0.0,0.0,74.5,Non-Progression,Non-Progression,SD,0.832,True,Predicted NON-PROGRESSION based on significant tumor reduction (-92%). Confidence: 83.2%.
Patient-037,week-000-2,week-002,-32.3,-55.7,0.0,0.0,-33.1,Progression,Non-Progression,SD,0.675,False,Predicted PROGRESSION due to region composition changes suggest progression despite 32% total volume decrease. Confidence: 67.5%.
Patient-037,week-000-2,week-015,82.9,80.0,0.0,0.0,-1.5,Progression,Non-Progression,SD,0.773,False,Predicted PROGRESSION due to tumor core (TC) increased by 80%. Confidence: 77.3%.
Patient-037,week-000-2,week-025,41.3,47.1,0.0,0.0,3.9,Progression,Non-Progression,SD,0.653,False,Predicted PROGRESSION due to tumor core (TC) increased by 47%. Confidence: 65.3%.
Patient-037,week-000-2,week-029,91.7,97.3,0.0,0.0,2.8,Progression,Progression,PD,0.729,True,Predicted PROGRESSION due to tumor core (TC) increased by 97%. Confidence: 72.9%.
Patient-037,week-000-2,week-037,96.2,103.4,0.0,0.0,3.5,Progression,Progression,PD,0.694,True,Predicted PROGRESSION due to tumor core (TC) increased by 103%. Confidence: 69.4%.
Patient-038,week-000,week-023,8.0,18.4,0.0,0.0,7.7,Progression,Progression,PD,0.624,True,Predicted PROGRESSION due to combined regional patterns indicate progression. Confidence: 62.4%.
Patient-039,week-000-2,week-017,-96.6,-96.8,0.0,0.0,-4.0,Non-Progression,Non-Progression,SD,0.848,True,Predicted NON-PROGRESSION based on significant tumor reduction (-97%). Confidence: 84.8%.
Patient-039,week-000-2,week-044,-29.5,-64.4,0.0,0.0,-49.5,Progression,Progression,PD,0.715,True,Predicted PROGRESSION due to region composition changes suggest progression despite 30% total volume decrease. Confidence: 71.5%.
Patient-040,week-000,week-015,671.9,675.1,0.0,0.0,0.4,Progression,Non-Progression,SD,0.797,False,Predicted PROGRESSION due to tumor core (TC) increased by 675%. Confidence: 79.7%.
Patient-040,week-000,week-028,851.5,730.9,0.0,0.0,-12.2,Progression,Progression,PD,0.745,True,Predicted PROGRESSION due to tumor core (TC) increased by 731%. Confidence: 74.5%.
Patient-041,week-000,week-020,-74.5,-50.1,0.0,0.0,35.1,Progression,Non-Progression,SD,0.609,False,Predicted PROGRESSION due to region composition changes suggest progression despite 75% total volume decrease. Confidence: 60.9%.
Patient-041,week-000,week-038,-92.2,-79.9,0.0,0.0,57.0,Non-Progression,Progression,PD,0.692,False,Predicted NON-PROGRESSION based on significant tumor reduction (-92%). Confidence: 69.2%.
Patient-042,week-000-2,week-004,-96.5,-97.0,0.0,0.0,-14.1,Non-Progression,Non-Progression,SD,0.762,True,Predicted NON-PROGRESSION based on significant tumor reduction (-96%). Confidence: 76.2%.
Patient-042,week-000-2,week-010,-99.9,-99.9,0.0,0.0,-100.0,Non-Progression,Non-Progression,SD,0.644,True,Predicted NON-PROGRESSION based on significant tumor reduction (-100%). Confidence: 64.4%.
Patient-042,week-000-2,week-010,-99.9,-99.9,0.0,0.0,-100.0,Non-Progression,Progression,PD,0.897,False,Predicted NON-PROGRESSION based on significant tumor reduction (-100%). Confidence: 89.7%.
Patient-042,week-000-2,week-022,-98.5,-98.5,0.0,0.0,0.0,Non-Progression,Non-Progression,SD,0.802,True,Predicted NON-PROGRESSION based on significant tumor reduction (-99%). Confidence: 80.2%.
Patient-042,week-000-2,week-035,-94.4,-94.4,0.0,0.0,0.0,Non-Progression,Non-Progression,SD,0.844,True,Predicted NON-PROGRESSION based on significant tumor reduction (-94%). Confidence: 84.4%.
Patient-042,week-000-2,week-055,-74.9,-77.8,0.0,0.0,-11.5,Non-Progression,Progression,PD,0.746,False,Predicted NON-PROGRESSION based on significant tumor reduction (-75%). Confidence: 74.6%.
Patient-042,week-000-2,week-060,-28.3,-32.5,0.0,0.0,-5.9,Progression,Progression,PD,0.678,True,Predicted PROGRESSION due to region composition changes suggest progression despite 28% total volume decrease. Confidence: 67.8%.
Patient-042,week-000-2,week-061-1,-21.8,-39.0,0.0,0.0,-21.9,Progression,Progression,PD,0.66,True,Predicted PROGRESSION due to region composition changes suggest progression despite 22% total volume decrease. Confidence: 66.0%.
Patient-042,week-000-2,week-078,75.2,41.3,0.0,0.0,-19.3,Progression,Progression,PD,0.608,True,Predicted PROGRESSION due to tumor core (TC) increased by 41%. Confidence: 60.8%.
Patient-042,week-000-2,week-081,377.6,256.0,0.0,0.0,-25.5,Progression,Progression,PD,0.836,True,Predicted PROGRESSION due to tumor core (TC) increased by 256%. Confidence: 83.6%.
Patient-043,week-000,week-018,-100.0,-100.0,0.0,0.0,-91.0,Non-Progression,Non-Progression,SD,0.73,True,Predicted NON-PROGRESSION based on significant tumor reduction (-100%). Confidence: 73.0%.
Patient-043,week-000,week-030,-100.0,-100.0,0.0,0.0,-91.0,Non-Progression,Non-Progression,SD,0.893,True,Predicted NON-PROGRESSION based on significant tumor reduction (-100%). Confidence: 89.3%.
Patient-043,week-000,week-041,-91.6,-90.8,0.0,0.0,9.0,Non-Progression,Non-Progression,SD,0.767,True,Predicted NON-PROGRESSION based on significant tumor reduction (-92%). Confidence: 76.7%.
Patient-043,week-000,week-053,-77.4,-75.2,0.0,0.0,9.0,Non-Progression,Non-Progression,SD,0.75,True,Predicted NON-PROGRESSION based on significant tumor reduction (-77%). Confidence: 75.0%.
Patient-043,week-000,week-067,-90.6,-89.7,0.0,0.0,9.0,Non-Progression,Progression,PD,0.858,False,Predicted NON-PROGRESSION based on significant tumor reduction (-91%). Confidence: 85.8%.
Patient-043,week-000,week-084,109.8,108.3,0.0,0.0,-0.6,Non-Progression,Progression,PD,0.665,False,Predicted NON-PROGRESSION based on regional features indicate stability. Confidence: 66.5%.
Patient-043,week-000,week-098,444.4,458.0,0.0,0.0,2.3,Progression,Progression,PD,0.502,True,Predicted PROGRESSION due to tumor core (TC) increased by 458%. Confidence: 50.2%.
Patient-043,week-000,week-106,1818.0,1867.7,0.0,0.0,2.4,Progression,Progression,PD,0.61,True,Predicted PROGRESSION due to tumor core (TC) increased by 1868%. Confidence: 61.0%.
Patient-043,week-000,week-116,2532.0,2087.3,0.0,0.0,-15.4,Progression,Progression,PD,0.756,True,Predicted PROGRESSION due to tumor core (TC) increased by 2087%. Confidence: 75.6%.
Patient-045,week-000-2,week-017,133.3,105.0,0.0,0.0,-12.1,Progression,Non-Progression,SD,0.639,False,Predicted PROGRESSION due to tumor core (TC) increased by 105%. Confidence: 63.9%.
Patient-045,week-000-2,week-028,441.6,421.0,0.0,0.0,-3.8,Progression,Progression,PD,0.649,True,Predicted PROGRESSION due to tumor core (TC) increased by 421%. Confidence: 64.9%.
Patient-046,week-000,week-016,0.0,44.0,0.0,0.0,28.2,Progression,Non-Progression,SD,0.513,False,Predicted PROGRESSION due to tumor core (TC) increased by 44%. Confidence: 51.3%.
Patient-046,week-000,week-064,549.2,628.4,0.0,0.0,7.7,Progression,Progression,PD,0.781,True,Predicted PROGRESSION due to tumor core (TC) increased by 628%. Confidence: 78.1%.
Patient-048,week-000-2,week-013,-95.2,-95.5,0.0,0.0,-7.0,Non-Progression,Non-Progression,SD,0.796,True,Predicted NON-PROGRESSION based on significant tumor reduction (-95%). Confidence: 79.6%.
Patient-048,week-000-2,week-023,-89.5,-90.1,0.0,0.0,-5.3,Non-Progression,Non-Progression,CR,0.693,True,Predicted NON-PROGRESSION based on significant tumor reduction (-90%). Confidence: 69.3%.
Patient-048,week-000-2,week-045,-86.0,-89.6,0.0,0.0,-25.8,Non-Progression,Progression,PD,0.725,False,Predicted NON-PROGRESSION based on significant tumor reduction (-86%). Confidence: 72.5%.
Patient-048,week-000-2,week-049,11.3,-19.3,0.0,0.0,-27.4,Progression,Progression,PD,0.673,True,Predicted PROGRESSION due to combined regional patterns indicate progression. Confidence: 67.3%.
Patient-049,week-000,week-019,571.2,656.3,0.0,0.0,10.0,Progression,Non-Progression,SD,0.803,False,Predicted PROGRESSION due to tumor core (TC) increased by 656%. Confidence: 80.3%.
Patient-049,week-000,week-029,373.4,425.1,0.0,0.0,8.6,Progression,Progression,PD,0.777,True,Predicted PROGRESSION due to tumor core (TC) increased by 425%. Confidence: 77.7%.
Patient-049,week-000,week-046,1136.4,1201.3,0.0,0.0,4.1,Progression,Progression,PD,0.815,True,Predicted PROGRESSION due to tumor core (TC) increased by 1201%. Confidence: 81.5%.
Patient-050,week-000,week-048,182.8,170.4,0.0,0.0,-3.8,Progression,Progression,PD,0.765,True,Predicted PROGRESSION due to tumor core (TC) increased by 170%. Confidence: 76.5%.
Patient-050,week-000,week-061,427.5,377.9,0.0,0.0,-8.1,Progression,Progression,PD,0.822,True,Predicted PROGRESSION due to tumor core (TC) increased by 378%. Confidence: 82.2%.
Patient-051,week-000-2,week-012,-32.4,-32.4,0.0,0.0,0.0,Progression,Non-Progression,SD,0.582,False,Predicted PROGRESSION due to region composition changes suggest progression despite 32% total volume decrease. Confidence: 58.2%.
Patient-051,week-000-2,week-023,22.4,7.7,0.0,0.0,-12.0,Progression,Progression,PD,0.696,True,Predicted PROGRESSION due to combined regional patterns indicate progression. Confidence: 69.6%.
Patient-051,week-000-2,week-036,-21.6,-23.7,0.0,0.0,-2.7,Progression,Progression,PD,0.743,True,Predicted PROGRESSION due to region composition changes suggest progression despite 22% total volume decrease. Confidence: 74.3%.
Patient-051,week-000-2,week-050,-33.4,-34.0,0.0,0.0,-0.9,Progression,Progression,PD,0.722,True,Predicted PROGRESSION due to region composition changes suggest progression despite 33% total volume decrease. Confidence: 72.2%.
Patient-051,week-000-2,week-064,-31.3,-31.4,0.0,0.0,-0.3,Progression,Progression,PD,0.686,True,Predicted PROGRESSION due to region composition changes suggest progression despite 31% total volume decrease. Confidence: 68.6%.
Patient-051,week-000-2,week-077,-27.2,-28.5,0.0,0.0,-1.8,Progression,Progression,PD,0.71,True,Predicted PROGRESSION due to region composition changes suggest progression despite 27% total volume decrease. Confidence: 71.0%.
Patient-051,week-000-2,week-089,-9.1,-33.7,0.0,0.0,-27.0,Progression,Progression,PD,0.788,True,Predicted PROGRESSION due to region composition changes suggest progression despite 9% total volume decrease. Confidence: 78.8%.
Patient-051,week-000-2,week-103,-0.2,-19.3,0.0,0.0,-19.1,Progression,Progression,PD,0.788,True,Predicted PROGRESSION due to region composition changes suggest progression despite 0% total volume decrease. Confidence: 78.8%.
Patient-052,week-000,week-089,-57.7,-50.5,0.0,0.0,13.7,Progression,Progression,PD,0.685,True,Predicted PROGRESSION due to region composition changes suggest progression despite 58% total volume decrease. Confidence: 68.5%.
Patient-052,week-000,week-115,-55.2,-45.9,0.0,0.0,16.6,Progression,Progression,PD,0.704,True,Predicted PROGRESSION due to region composition changes suggest progression despite 55% total volume decrease. Confidence: 70.4%.
Patient-052,week-000,week-133,-45.3,-31.9,0.0,0.0,19.6,Non-Progression,Progression,PD,0.572,False,Predicted NON-PROGRESSION based on significant tumor reduction (-45%). Confidence: 57.2%.
Patient-052,week-000,week-148,-37.4,-24.2,0.0,0.0,16.9,Progression,Progression,PD,0.696,True,Predicted PROGRESSION due to region composition changes suggest progression despite 37% total volume decrease. Confidence: 69.6%.
Patient-052,week-000,week-168,-20.0,-9.2,0.0,0.0,10.9,Progression,Progression,PD,0.721,True,Predicted PROGRESSION due to region composition changes suggest progression despite 20% total volume decrease. Confidence: 72.1%.
Patient-055,week-000-2,week-017,-96.3,-95.9,0.0,0.0,10.2,Non-Progression,Non-Progression,SD,0.717,True,Predicted NON-PROGRESSION based on significant tumor reduction (-96%). Confidence: 71.7%.
Patient-055,week-000-2,week-039,-93.2,-92.3,0.0,0.0,11.5,Non-Progression,Progression,PD,0.575,False,Predicted NON-PROGRESSION based on significant tumor reduction (-93%). Confidence: 57.5%.
Patient-055,week-000-2,week-054,-93.1,-92.2,0.0,0.0,11.5,Non-Progression,Progression,PD,0.591,False,Predicted NON-PROGRESSION based on significant tumor reduction (-93%). Confidence: 59.1%.
Patient-055,week-000-2,week-067,-91.2,-90.1,0.0,0.0,11.5,Non-Progression,Progression,PD,0.534,False,Predicted NON-PROGRESSION based on significant tumor reduction (-91%). Confidence: 53.4%.
Patient-055,week-000-2,week-084,-53.9,-52.4,0.0,0.0,2.9,Progression,Progression,PD,0.739,True,Predicted PROGRESSION due to region composition changes suggest progression despite 54% total volume decrease. Confidence: 73.9%.
Patient-055,week-000-2,week-099,-64.6,-67.0,0.0,0.0,-6.1,Progression,Progression,PD,0.742,True,Predicted PROGRESSION due to region composition changes suggest progression despite 65% total volume decrease. Confidence: 74.2%.
Patient-055,week-000-2,week-118,-51.9,-82.0,0.0,0.0,-55.3,Progression,Progression,PD,0.788,True,Predicted PROGRESSION due to region composition changes suggest progression despite 52% total volume decrease. Confidence: 78.8%.
Patient-059,week-000,week-014,568.7,1245.0,0.0,0.0,47.7,Progression,Progression,PD,0.67,True,Predicted PROGRESSION due to tumor core (TC) increased by 1245%. Confidence: 67.0%.
Patient-059,week-000,week-024,1013.8,2052.0,0.0,0.0,44.0,Progression,Progression,PD,0.789,True,Predicted PROGRESSION due to tumor core (TC) increased by 2052%. Confidence: 78.9%.
Patient-059,week-000,week-040,742.9,1544.1,0.0,0.0,44.9,Progression,Progression,PD,0.686,True,Predicted PROGRESSION due to tumor core (TC) increased by 1544%. Confidence: 68.6%.
Patient-059,week-000,week-055,268.2,639.5,0.0,0.0,47.6,Progression,Non-Progression,PR,0.611,False,Predicted PROGRESSION due to tumor core (TC) increased by 639%. Confidence: 61.1%.
Patient-059,week-000,week-068,241.0,617.6,0.0,0.0,52.1,Progression,Progression,PD,0.52,True,Predicted PROGRESSION due to tumor core (TC) increased by 618%. Confidence: 52.0%.
Patient-059,week-000,week-084,355.3,837.1,0.0,0.0,49.9,Progression,Progression,PD,0.609,True,Predicted PROGRESSION due to tumor core (TC) increased by 837%. Confidence: 60.9%.
Patient-059,week-000,week-100,230.5,598.0,0.0,0.0,52.5,Progression,Non-Progression,PR,0.558,False,Predicted PROGRESSION due to tumor core (TC) increased by 598%. Confidence: 55.8%.
Patient-059,week-000,week-116,181.8,494.7,0.0,0.0,52.4,Progression,Non-Progression,PR,0.515,False,Predicted PROGRESSION due to tumor core (TC) increased by 495%. Confidence: 51.5%.
Patient-059,week-000,week-136,152.1,422.0,0.0,0.0,50.5,Progression,Progression,PD,0.535,True,Predicted PROGRESSION due to tumor core (TC) increased by 422%. Confidence: 53.5%.
Patient-060,week-000,week-031,-97.5,-96.9,0.0,0.0,19.7,Non-Progression,Non-Progression,SD,0.809,True,Predicted NON-PROGRESSION based on significant tumor reduction (-98%). Confidence: 80.9%.
Patient-060,week-000,week-052,-94.1,-92.7,0.0,0.0,19.7,Non-Progression,Non-Progression,SD,0.838,True,Predicted NON-PROGRESSION based on significant tumor reduction (-94%). Confidence: 83.8%.
Patient-060,week-000,week-065,-87.5,-85.3,0.0,0.0,14.5,Non-Progression,Progression,PD,0.638,False,Predicted NON-PROGRESSION based on significant tumor reduction (-88%). Confidence: 63.8%.
Patient-060,week-000,week-088,-67.6,-61.2,0.0,0.0,15.8,Progression,Progression,PD,0.69,True,Predicted PROGRESSION due to region composition changes suggest progression despite 68% total volume decrease. Confidence: 69.0%.
Patient-061,week-000-2,week-022,-65.8,-66.1,0.0,0.0,-0.7,Progression,Progression,PD,0.69,True,Predicted PROGRESSION due to region composition changes suggest progression despite 66% total volume decrease. Confidence: 69.0%.
Patient-061,week-000-2,week-027,-61.6,-61.8,0.0,0.0,-0.4,Progression,Progression,PD,0.598,True,Predicted PROGRESSION due to region composition changes suggest progression despite 62% total volume decrease. Confidence: 59.8%.
Patient-061,week-000-2,week-034,-61.3,-61.5,0.0,0.0,-0.7,Progression,Progression,PD,0.665,True,Predicted PROGRESSION due to region composition changes suggest progression despite 61% total volume decrease. Confidence: 66.5%.
Patient-061,week-000-2,week-054,87.6,79.9,0.0,0.0,-4.1,Progression,Progression,PD,0.772,True,Predicted PROGRESSION due to tumor core (TC) increased by 80%. Confidence: 77.2%.
Patient-062,week-000-2,week-015,-85.1,-85.1,0.0,0.0,0.5,Non-Progression,Non-Progression,SD,0.806,True,Predicted NON-PROGRESSION based on significant tumor reduction (-85%). Confidence: 80.6%.
Patient-062,week-000-2,week-030,-58.4,-58.2,0.0,0.0,0.5,Non-Progression,Non-Progression,SD,0.506,True,Predicted NON-PROGRESSION based on significant tumor reduction (-58%). Confidence: 50.6%.
Patient-062,week-000-2,week-042,-48.7,-48.5,0.0,0.0,0.5,Non-Progression,Non-Progression,SD,0.504,True,Predicted NON-PROGRESSION based on significant tumor reduction (-49%). Confidence: 50.4%.
Patient-062,week-000-2,week-050,-24.1,-23.7,0.0,0.0,0.5,Non-Progression,Progression,PD,0.576,False,Predicted NON-PROGRESSION based on stable total volume (change: -24%). Confidence: 57.6%.
Patient-062,week-000-2,week-057,-18.0,-17.6,0.0,0.0,0.5,Non-Progression,Progression,PD,0.549,False,Predicted NON-PROGRESSION based on stable total volume (change: -18%). Confidence: 54.9%.
Patient-062,week-000-2,week-064,121.3,112.7,0.0,0.0,-3.9,Progression,Progression,PD,0.847,True,Predicted PROGRESSION due to tumor core (TC) increased by 113%. Confidence: 84.7%.
Patient-064,week-000,week-020,-51.3,-50.9,0.0,0.0,0.9,Non-Progression,Non-Progression,SD,0.509,True,Predicted NON-PROGRESSION based on significant tumor reduction (-51%). Confidence: 50.9%.
Patient-064,week-000,week-033,-53.0,-53.5,0.0,0.0,-1.0,Progression,Progression,PD,0.706,True,Predicted PROGRESSION due to region composition changes suggest progression despite 53% total volume decrease. Confidence: 70.6%.
Patient-064,week-000,week-049,-53.0,-52.6,0.0,0.0,0.9,Non-Progression,Non-Progression,SD,0.526,True,Predicted NON-PROGRESSION based on significant tumor reduction (-53%). Confidence: 52.6%.
Patient-064,week-000,week-062,-56.4,-56.8,0.0,0.0,-0.9,Progression,Progression,PD,0.713,True,Predicted PROGRESSION due to region composition changes suggest progression despite 56% total volume decrease. Confidence: 71.3%.
Patient-065,week-000-2,week-014,-55.1,-56.2,0.0,0.0,-2.2,Progression,Non-Progression,SD,0.631,False,Predicted PROGRESSION due to region composition changes suggest progression despite 55% total volume decrease. Confidence: 63.1%.
Patient-065,week-000-2,week-021,-36.8,-36.9,0.0,0.0,-0.1,Progression,Progression,PD,0.616,True,Predicted PROGRESSION due to region composition changes suggest progression despite 37% total volume decrease. Confidence: 61.6%.
Patient-065,week-000-2,week-029,-42.5,-41.9,0.0,0.0,1.1,Non-Progression,Progression,PD,0.558,False,Predicted NON-PROGRESSION based on significant tumor reduction (-43%). Confidence: 55.8%.
Patient-065,week-000-2,week-079,918.4,713.4,0.0,0.0,-19.9,Progression,Progression,PD,0.775,True,Predicted PROGRESSION due to tumor core (TC) increased by 713%. Confidence: 77.5%.
Patient-065,week-000-2,week-102,312.3,47.7,0.0,0.0,-63.5,Progression,Progression,PD,0.698,True,Predicted PROGRESSION due to tumor core (TC) increased by 48%. Confidence: 69.8%.
Patient-066,week-000,week-016,-99.1,-98.8,0.0,0.0,23.1,Non-Progression,Non-Progression,SD,0.705,True,Predicted NON-PROGRESSION based on significant tumor reduction (-99%). Confidence: 70.5%.
Patient-066,week-000,week-031,-95.5,-94.1,0.0,0.0,23.1,Non-Progression,Progression,PD,0.696,False,Predicted NON-PROGRESSION based on significant tumor reduction (-95%). Confidence: 69.6%.
Patient-066,week-000,week-046,-93.6,-91.8,0.0,0.0,21.5,Non-Progression,Progression,PD,0.521,False,Predicted NON-PROGRESSION based on significant tumor reduction (-94%). Confidence: 52.1%.
Patient-066,week-000,week-068,-87.4,-84.4,0.0,0.0,18.7,Progression,Progression,PD,0.57,True,Predicted PROGRESSION due to region composition changes suggest progression despite 87% total volume decrease. Confidence: 57.0%.
Patient-066,week-000,week-084,-69.5,-78.1,0.0,0.0,-21.7,Progression,Progression,PD,0.65,True,Predicted PROGRESSION due to region composition changes suggest progression despite 69% total volume decrease. Confidence: 65.0%.
Patient-066,week-000,week-101,-81.2,-76.1,0.0,0.0,21.0,Progression,Progression,PD,0.56,True,Predicted PROGRESSION due to region composition changes suggest progression despite 81% total volume decrease. Confidence: 56.0%.
Patient-067,week-000-2,week-013,352.2,325.2,0.0,0.0,-6.0,Progression,Progression,PD,0.593,True,Predicted PROGRESSION due to tumor core (TC) increased by 325%. Confidence: 59.3%.
Patient-067,week-000-2,week-033,421.8,421.8,0.0,0.0,0.0,Progression,Progression,PD,0.539,True,Predicted PROGRESSION due to tumor core (TC) increased by 422%. Confidence: 53.9%.
Patient-067,week-000-2,week-042,113.3,113.3,0.0,0.0,0.0,Non-Progression,Progression,PD,0.517,False,Predicted NON-PROGRESSION based on regional features indicate stability. Confidence: 51.7%.
Patient-067,week-000-2,week-053,147.4,142.1,0.0,0.0,-2.1,Progression,Progression,PD,0.603,True,Predicted PROGRESSION due to tumor core (TC) increased by 142%. Confidence: 60.3%.
Patient-067,week-000-2,week-068,387.0,339.4,0.0,0.0,-9.8,Progression,Non-Progression,SD,0.624,False,Predicted PROGRESSION due to tumor core (TC) increased by 339%. Confidence: 62.4%.
Patient-067,week-000-2,week-073,610.1,562.1,0.0,0.0,-6.8,Progression,Non-Progression,SD,0.76,False,Predicted PROGRESSION due to tumor core (TC) increased by 562%. Confidence: 76.0%.
Patient-067,week-000-2,week-077,477.6,466.6,0.0,0.0,-1.9,Progression,Non-Progression,SD,0.596,False,Predicted PROGRESSION due to tumor core (TC) increased by 467%. Confidence: 59.6%.
Patient-067,week-000-2,week-079,501.4,496.6,0.0,0.0,-0.8,Progression,Non-Progression,SD,0.7,False,Predicted PROGRESSION due to tumor core (TC) increased by 497%. Confidence: 70.0%.
Patient-067,week-000-2,week-092,343.7,343.7,0.0,0.0,0.0,Progression,Non-Progression,SD,0.581,False,Predicted PROGRESSION due to tumor core (TC) increased by 344%. Confidence: 58.1%.
Patient-067,week-000-2,week-109,491.8,491.8,0.0,0.0,0.0,Progression,Progression,PD,0.546,True,Predicted PROGRESSION due to tumor core (TC) increased by 492%. Confidence: 54.6%.
Patient-067,week-000-2,week-124,494.1,494.1,0.0,0.0,0.0,Progression,Progression,PD,0.543,True,Predicted PROGRESSION due to tumor core (TC) increased by 494%. Confidence: 54.3%.
Patient-067,week-000-2,week-136,477.2,477.2,0.0,0.0,0.0,Progression,Progression,PD,0.6,True,Predicted PROGRESSION due to tumor core (TC) increased by 477%. Confidence: 60.0%.
Patient-067,week-000-2,week-152,1415.8,1205.1,0.0,0.0,-13.9,Progression,Progression,PD,0.829,True,Predicted PROGRESSION due to tumor core (TC) increased by 1205%. Confidence: 82.9%.
Patient-067,week-000-2,week-156,1921.3,1529.4,0.0,0.0,-19.4,Progression,Progression,PD,0.729,True,Predicted PROGRESSION due to tumor core (TC) increased by 1529%. Confidence: 72.9%.
Patient-067,week-000-2,week-167,2225.9,1324.0,0.0,0.0,-38.8,Progression,Progression,PD,0.76,True,Predicted PROGRESSION due to tumor core (TC) increased by 1324%. Confidence: 76.0%.
Patient-068,week-000-2,week-004,158.9,148.6,0.0,0.0,-4.0,Progression,Progression,PD,0.611,True,Predicted PROGRESSION due to tumor core (TC) increased by 149%. Confidence: 61.1%.
Patient-068,week-000-2,week-010,22.4,20.0,0.0,0.0,-1.9,Progression,Non-Progression,PR,0.519,False,Predicted PROGRESSION due to combined regional patterns indicate progression. Confidence: 51.9%.
Patient-068,week-000-2,week-022,-39.0,-39.0,0.0,0.0,0.0,Non-Progression,Non-Progression,PR,0.695,True,Predicted NON-PROGRESSION based on significant tumor reduction (-39%). Confidence: 69.5%.
Patient-068,week-000-2,week-035,482.3,387.7,0.0,0.0,-16.2,Progression,Progression,PD,0.635,True,Predicted PROGRESSION due to tumor core (TC) increased by 388%. Confidence: 63.5%.
Patient-068,week-000-2,week-047,2008.6,577.8,0.0,0.0,-67.9,Progression,Progression,PD,0.745,True,Predicted PROGRESSION due to tumor core (TC) increased by 578%. Confidence: 74.5%.
Patient-071,week-000-2,week-024,-68.8,-69.0,0.0,0.0,-0.7,Progression,Progression,PD,0.706,True,Predicted PROGRESSION due to region composition changes suggest progression despite 69% total volume decrease. Confidence: 70.6%.
Patient-071,week-000-2,week-027,-68.2,-69.3,0.0,0.0,-3.5,Progression,Progression,PD,0.712,True,Predicted PROGRESSION due to region composition changes suggest progression despite 68% total volume decrease. Confidence: 71.2%.
Patient-071,week-000-2,week-052,-45.1,-53.7,0.0,0.0,-15.7,Progression,Progression,PD,0.725,True,Predicted PROGRESSION due to region composition changes suggest progression despite 45% total volume decrease. Confidence: 72.5%.
Patient-071,week-000-2,week-058,-11.0,-22.8,0.0,0.0,-13.3,Progression,Progression,PD,0.801,True,Predicted PROGRESSION due to region composition changes suggest progression despite 11% total volume decrease. Confidence: 80.1%.
Patient-071,week-000-2,week-062,-38.0,-62.2,0.0,0.0,-39.0,Progression,Progression,PD,0.796,True,Predicted PROGRESSION due to region composition changes suggest progression despite 38% total volume decrease. Confidence: 79.6%.
Patient-072,week-000-2,week-013,-60.5,-74.0,0.0,0.0,-32.5,Progression,Non-Progression,SD,0.669,False,Predicted PROGRESSION due to region composition changes suggest progression despite 60% total volume decrease. Confidence: 66.9%.
Patient-072,week-000-2,week-021,-14.0,-37.7,0.0,0.0,-26.1,Progression,Progression,PD,0.703,True,Predicted PROGRESSION due to region composition changes suggest progression despite 14% total volume decrease. Confidence: 70.3%.
Patient-072,week-000-2,week-029,14.2,-8.1,0.0,0.0,-18.5,Progression,Progression,PD,0.705,True,Predicted PROGRESSION due to combined regional patterns indicate progression. Confidence: 70.5%.
Patient-072,week-000-2,week-037,7.4,-7.6,0.0,0.0,-13.2,Progression,Non-Progression,PR,0.725,False,Predicted PROGRESSION due to combined regional patterns indicate progression. Confidence: 72.5%.
Patient-072,week-000-2,week-046,-17.5,-23.3,0.0,0.0,-6.7,Progression,Progression,PD,0.692,True,Predicted PROGRESSION due to region composition changes suggest progression despite 18% total volume decrease. Confidence: 69.2%.
Patient-072,week-000-2,week-055,-17.1,-18.0,0.0,0.0,-1.0,Progression,Progression,PD,0.7,True,Predicted PROGRESSION due to region composition changes suggest progression despite 17% total volume decrease. Confidence: 70.0%.
Patient-072,week-000-2,week-064,-16.7,-15.1,0.0,0.0,1.8,Progression,Progression,PD,0.7,True,Predicted PROGRESSION due to region composition changes suggest progression despite 17% total volume decrease. Confidence: 70.0%.
Patient-072,week-000-2,week-073,-17.9,-17.9,0.0,0.0,-0.0,Progression,Progression,PD,0.694,True,Predicted PROGRESSION due to region composition changes suggest progression despite 18% total volume decrease. Confidence: 69.4%.
Patient-072,week-000-2,week-078,-7.6,-9.4,0.0,0.0,-1.9,Progression,Progression,PD,0.721,True,Predicted PROGRESSION due to region composition changes suggest progression despite 8% total volume decrease. Confidence: 72.1%.
Patient-072,week-000-2,week-090,1.4,2.3,0.0,0.0,0.9,Progression,Progression,PD,0.681,True,Predicted PROGRESSION due to combined regional patterns indicate progression. Confidence: 68.1%.
Patient-072,week-000-2,week-105,-8.0,-6.8,0.0,0.0,1.3,Progression,Progression,PD,0.671,True,Predicted PROGRESSION due to region composition changes suggest progression despite 8% total volume decrease. Confidence: 67.1%.
Patient-073,week-000,week-015,-98.6,-98.6,0.0,0.0,-1.7,Non-Progression,Non-Progression,SD,0.734,True,Predicted NON-PROGRESSION based on significant tumor reduction (-99%). Confidence: 73.4%.
Patient-073,week-000,week-032,-95.6,-94.5,0.0,0.0,19.5,Non-Progression,Non-Progression,SD,0.724,True,Predicted NON-PROGRESSION based on significant tumor reduction (-96%). Confidence: 72.4%.
Patient-073,week-000,week-046,-90.4,-88.1,0.0,0.0,19.5,Non-Progression,Non-Progression,SD,0.577,True,Predicted NON-PROGRESSION based on significant tumor reduction (-90%). Confidence: 57.7%.
Patient-073,week-000,week-060,-89.4,-86.8,0.0,0.0,19.5,Non-Progression,Non-Progression,SD,0.581,True,Predicted NON-PROGRESSION based on significant tumor reduction (-89%). Confidence: 58.1%.
Patient-073,week-000,week-087,-86.6,-83.4,0.0,0.0,19.5,Non-Progression,Progression,PD,0.738,False,Predicted NON-PROGRESSION based on significant tumor reduction (-87%). Confidence: 73.8%.
Patient-073,week-000,week-100,-87.9,-85.1,0.0,0.0,18.2,Progression,Progression,PD,0.603,True,Predicted PROGRESSION due to region composition changes suggest progression despite 88% total volume decrease. Confidence: 60.3%.
Patient-073,week-000,week-119,-82.7,-78.6,0.0,0.0,19.5,Non-Progression,Progression,PD,0.755,False,Predicted NON-PROGRESSION based on significant tumor reduction (-83%). Confidence: 75.5%.
Patient-073,week-000,week-135,-79.6,-74.6,0.0,0.0,19.5,Non-Progression,Non-Progression,SD,0.668,True,Predicted NON-PROGRESSION based on significant tumor reduction (-80%). Confidence: 66.8%.
Patient-073,week-000,week-155,-81.5,-77.0,0.0,0.0,19.5,Non-Progression,Non-Progression,SD,0.615,True,Predicted NON-PROGRESSION based on significant tumor reduction (-81%). Confidence: 61.5%.
Patient-073,week-000,week-169,-79.3,-74.3,0.0,0.0,19.5,Non-Progression,Non-Progression,SD,0.685,True,Predicted NON-PROGRESSION based on significant tumor reduction (-79%). Confidence: 68.5%.
Patient-073,week-000,week-186,-70.8,-63.8,0.0,0.0,19.5,Non-Progression,Non-Progression,SD,0.669,True,Predicted NON-PROGRESSION based on significant tumor reduction (-71%). Confidence: 66.9%.
Patient-073,week-000,week-202,-73.4,-67.0,0.0,0.0,19.5,Non-Progression,Non-Progression,SD,0.605,True,Predicted NON-PROGRESSION based on significant tumor reduction (-73%). Confidence: 60.5%.
Patient-073,week-000,week-216,-64.7,-60.2,0.0,0.0,10.2,Progression,Progression,PD,0.744,True,Predicted PROGRESSION due to region composition changes suggest progression despite 65% total volume decrease. Confidence: 74.4%.
Patient-073,week-000,week-228,-65.6,-62.5,0.0,0.0,7.2,Progression,Progression,PD,0.713,True,Predicted PROGRESSION due to region composition changes suggest progression despite 66% total volume decrease. Confidence: 71.3%.
Patient-073,week-000,week-242,-62.7,-63.2,0.0,0.0,-1.0,Progression,Progression,PD,0.774,True,Predicted PROGRESSION due to region composition changes suggest progression despite 63% total volume decrease. Confidence: 77.4%.
Patient-074,week-000-2,week-026,-31.9,-30.7,0.0,0.0,1.9,Non-Progression,Progression,PD,0.568,False,Predicted NON-PROGRESSION based on significant tumor reduction (-32%). Confidence: 56.8%.
Patient-074,week-000-2,week-039,-19.1,-52.7,0.0,0.0,-40.7,Progression,Progression,PD,0.615,True,Predicted PROGRESSION due to region composition changes suggest progression despite 19% total volume decrease. Confidence: 61.5%.
Patient-075,week-000,week-020,-60.8,-54.8,0.0,0.0,12.1,Non-Progression,Non-Progression,SD,0.699,True,Predicted NON-PROGRESSION based on significant tumor reduction (-61%). Confidence: 69.9%.
Patient-075,week-000,week-032,274.8,371.2,0.0,0.0,20.5,Progression,Progression,PD,0.579,True,Predicted PROGRESSION due to tumor core (TC) increased by 371%. Confidence: 57.9%.
Patient-075,week-000,week-044,115.9,168.5,0.0,0.0,19.4,Progression,Non-Progression,PR,0.617,False,Predicted PROGRESSION due to tumor core (TC) increased by 168%. Confidence: 61.7%.
Patient-077,week-000,week-014,-96.7,-96.2,0.0,0.0,13.1,Non-Progression,Non-Progression,SD,0.706,True,Predicted NON-PROGRESSION based on significant tumor reduction (-97%). Confidence: 70.6%.
Patient-077,week-000,week-026,-88.1,-87.8,0.0,0.0,2.1,Progression,Progression,PD,0.627,True,Predicted PROGRESSION due to region composition changes suggest progression despite 88% total volume decrease. Confidence: 62.7%.
Patient-077,week-000,week-048,-80.9,-78.3,0.0,0.0,11.9,Progression,Progression,PD,0.636,True,Predicted PROGRESSION due to region composition changes suggest progression despite 81% total volume decrease. Confidence: 63.6%.
Patient-077,week-000,week-062,-70.4,-69.3,0.0,0.0,3.2,Progression,Progression,PD,0.638,True,Predicted PROGRESSION due to region composition changes suggest progression despite 70% total volume decrease. Confidence: 63.8%.
Patient-077,week-000,week-070,-76.9,-81.2,0.0,0.0,-16.2,Progression,Progression,PD,0.678,True,Predicted PROGRESSION due to region composition changes suggest progression despite 77% total volume decrease. Confidence: 67.8%.
Patient-077,week-000,week-083,-47.8,-70.9,0.0,0.0,-38.5,Progression,Progression,PD,0.802,True,Predicted PROGRESSION due to region composition changes suggest progression despite 48% total volume decrease. Confidence: 80.2%.
Patient-078,week-000,week-005,-87.8,-87.5,0.0,0.0,2.3,Progression,Non-Progression,SD,0.59,False,Predicted PROGRESSION due to region composition changes suggest progression despite 88% total volume decrease. Confidence: 59.0%.
Patient-078,week-000,week-019,-54.5,-45.4,0.0,0.0,15.2,Progression,Non-Progression,SD,0.732,False,Predicted PROGRESSION due to region composition changes suggest progression despite 54% total volume decrease. Confidence: 73.2%.
Patient-078,week-000,week-029,-47.8,-40.1,0.0,0.0,11.1,Progression,Progression,PD,0.746,True,Predicted PROGRESSION due to region composition changes suggest progression despite 48% total volume decrease. Confidence: 74.6%.
Patient-078,week-000,week-037,-43.7,-37.3,0.0,0.0,8.7,Progression,Progression,PD,0.755,True,Predicted PROGRESSION due to region composition changes suggest progression despite 44% total volume decrease. Confidence: 75.5%.
Patient-078,week-000,week-039,-55.4,-46.3,0.0,0.0,15.6,Progression,Progression,PD,0.703,True,Predicted PROGRESSION due to region composition changes suggest progression despite 55% total volume decrease. Confidence: 70.3%.
Patient-078,week-000,week-041,-68.4,-64.5,0.0,0.0,9.5,Progression,Progression,PD,0.734,True,Predicted PROGRESSION due to region composition changes suggest progression despite 68% total volume decrease. Confidence: 73.4%.
Patient-078,week-000,week-045,-76.9,-72.3,0.0,0.0,15.2,Progression,Progression,PD,0.689,True,Predicted PROGRESSION due to region composition changes suggest progression despite 77% total volume decrease. Confidence: 68.9%.
Patient-078,week-000,week-056,-78.4,-75.6,0.0,0.0,9.8,Progression,Progression,PD,0.659,True,Predicted PROGRESSION due to region composition changes suggest progression despite 78% total volume decrease. Confidence: 65.9%.
Patient-078,week-000,week-062,-73.4,-69.9,0.0,0.0,10.1,Progression,Progression,PD,0.688,True,Predicted PROGRESSION due to region composition changes suggest progression despite 73% total volume decrease. Confidence: 68.8%.
Patient-078,week-000,week-076,-69.9,-64.8,0.0,0.0,12.9,Progression,Progression,PD,0.708,True,Predicted PROGRESSION due to region composition changes suggest progression despite 70% total volume decrease. Confidence: 70.8%.
Patient-078,week-000,week-088,-68.8,-62.8,0.0,0.0,14.8,Progression,Progression,PD,0.738,True,Predicted PROGRESSION due to region composition changes suggest progression despite 69% total volume decrease. Confidence: 73.8%.
Patient-078,week-000,week-106,-64.6,-55.5,0.0,0.0,19.7,Progression,Non-Progression,PR,0.687,False,Predicted PROGRESSION due to region composition changes suggest progression despite 65% total volume decrease. Confidence: 68.7%.
Patient-078,week-000,week-113,-65.4,-58.3,0.0,0.0,15.9,Progression,Progression,PD,0.729,True,Predicted PROGRESSION due to region composition changes suggest progression despite 65% total volume decrease. Confidence: 72.9%.
Patient-078,week-000,week-116,-64.3,-59.4,0.0,0.0,10.6,Progression,Progression,PD,0.744,True,Predicted PROGRESSION due to region composition changes suggest progression despite 64% total volume decrease. Confidence: 74.4%.
Patient-078,week-000,week-119,-50.9,-46.5,0.0,0.0,6.9,Progression,Progression,PD,0.747,True,Predicted PROGRESSION due to region composition changes suggest progression despite 51% total volume decrease. Confidence: 74.7%.
Patient-080,week-000,week-018,-71.5,-57.2,0.0,0.0,32.9,Progression,Non-Progression,SD,0.625,False,Predicted PROGRESSION due to region composition changes suggest progression despite 71% total volume decrease. Confidence: 62.5%.
Patient-081,week-000-2,week-006,-20.5,-71.4,0.0,0.0,-63.9,Progression,Progression,PD,0.66,True,Predicted PROGRESSION due to region composition changes suggest progression despite 21% total volume decrease. Confidence: 66.0%.
Patient-082,week-000-2,week-003,-92.5,-95.2,0.0,0.0,-36.6,Non-Progression,Non-Progression,SD,0.633,True,Predicted NON-PROGRESSION based on significant tumor reduction (-92%). Confidence: 63.3%.
Patient-083,week-000,week-002,-69.0,-65.1,0.0,0.0,10.8,Progression,Non-Progression,Post-Op ,0.705,False,Predicted PROGRESSION due to region composition changes suggest progression despite 69% total volume decrease. Confidence: 70.5%.
Patient-084,week-000-2,week-012,-23.4,-41.0,0.0,0.0,-22.9,Progression,Non-Progression,SD,0.805,False,Predicted PROGRESSION due to region composition changes suggest progression despite 23% total volume decrease. Confidence: 80.5%.
Patient-085,week-000-2,week-018,-12.7,-18.6,0.0,0.0,-6.7,Progression,Progression,PD,0.709,True,Predicted PROGRESSION due to region composition changes suggest progression despite 13% total volume decrease. Confidence: 70.9%.
Patient-085,week-000-2,week-042,-24.8,-24.4,0.0,0.0,0.4,Non-Progression,Progression,PD,0.509,False,Predicted NON-PROGRESSION based on stable total volume (change: -25%). Confidence: 50.9%.
Patient-085,week-000-2,week-050,5.9,-3.8,0.0,0.0,-9.1,Progression,Progression,PD,0.771,True,Predicted PROGRESSION due to combined regional patterns indicate progression. Confidence: 77.1%.
Patient-086,week-000,week-173-1,-44.5,-49.3,0.0,0.0,-6.1,Progression,Progression,PD,0.739,True,Predicted PROGRESSION due to region composition changes suggest progression despite 45% total volume decrease. Confidence: 73.9%.
Patient-086,week-000,week-181,-22.9,-20.2,0.0,0.0,2.5,Progression,Progression,PD,0.743,True,Predicted PROGRESSION due to region composition changes suggest progression despite 23% total volume decrease. Confidence: 74.3%.
Patient-087,week-000-2,week-024,-59.5,-58.2,0.0,0.0,3.1,Non-Progression,Progression,PD,0.779,False,Predicted NON-PROGRESSION based on significant tumor reduction (-59%). Confidence: 77.9%.
Patient-089,week-000-2,week-045,-68.5,-77.8,0.0,0.0,-29.5,Progression,Progression,PD,0.709,True,Predicted PROGRESSION due to region composition changes suggest progression despite 69% total volume decrease. Confidence: 70.9%.
Patient-089,week-000-2,week-046,-78.7,-79.7,0.0,0.0,-5.0,Progression,Non-Progression,Post-Op/PD,0.694,False,Predicted PROGRESSION due to region composition changes suggest progression despite 79% total volume decrease. Confidence: 69.4%.
Patient-089,week-000-2,week-056,-87.8,-89.3,0.0,0.0,-12.8,Progression,Progression,PD,0.568,True,Predicted PROGRESSION due to region composition changes suggest progression despite 88% total volume decrease. Confidence: 56.8%.
Patient-089,week-000-2,week-064,-78.7,-80.7,0.0,0.0,-9.8,Progression,Progression,PD,0.694,True,Predicted PROGRESSION due to region composition changes suggest progression despite 79% total volume decrease. Confidence: 69.4%.
Patient-090,week-000-2,week-029,47.7,48.2,0.0,0.0,0.3,Non-Progression,Progression,PD,0.599,False,Predicted NON-PROGRESSION based on regional features indicate stability. Confidence: 59.9%.
Patient-091,week-000,week-001,-11.4,-10.1,0.0,0.0,1.4,Progression,Non-Progression,Post-Op ,0.565,False,Predicted PROGRESSION due to region composition changes suggest progression despite 11% total volume decrease. Confidence: 56.5%.
Patient-091,week-000,week-014,-65.0,-64.6,0.0,0.0,1.3,Progression,Progression,PD,0.578,True,Predicted PROGRESSION due to region composition changes suggest progression despite 65% total volume decrease. Confidence: 57.8%.
Patient-091,week-000,week-026,-56.5,-56.0,0.0,0.0,1.2,Progression,Progression,PD,0.594,True,Predicted PROGRESSION due to region composition changes suggest progression despite 56% total volume decrease. Confidence: 59.4%.
Patient-091,week-000,week-036,-56.6,-55.9,0.0,0.0,1.6,Non-Progression,Progression,PD,0.566,False,Predicted NON-PROGRESSION based on significant tumor reduction (-57%). Confidence: 56.6%.
Patient-091,week-000,week-043,-57.8,-57.3,0.0,0.0,1.1,Progression,Progression,PD,0.615,True,Predicted PROGRESSION due to region composition changes suggest progression despite 58% total volume decrease. Confidence: 61.5%.
